DrugPatentWatch Database Preview

Servier Company Profile

Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for SERVIER, and what generic alternatives to SERVIER drugs are available?

SERVIER has one approved drug.

There are seven US patents protecting SERVIER drugs.

There are ninety-two patent family members on SERVIER drugs in thirty-five countries.

Summary for Servier

International Patents:	92
US Patents:	7
Tradenames:	1
Ingredients:	1
NDAs:	1

Drugs and US Patents for Servier

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Servier	TIBSOVO	ivosidenib	TABLET;ORAL	211192-001	Jul 20, 2018		RX	Yes	Yes
Servier	TIBSOVO	ivosidenib	TABLET;ORAL	211192-001	Jul 20, 2018		RX	Yes	Yes	10,980,788
Servier	TIBSOVO	ivosidenib	TABLET;ORAL	211192-001	Jul 20, 2018		RX	Yes	Yes
Servier	TIBSOVO	ivosidenib	TABLET;ORAL	211192-001	Jul 20, 2018		RX	Yes	Yes	10,449,184		Y
Servier	TIBSOVO	ivosidenib	TABLET;ORAL	211192-001	Jul 20, 2018		RX	Yes	Yes	9,474,779		Y	Y
Servier	TIBSOVO	ivosidenib	TABLET;ORAL	211192-001	Jul 20, 2018		RX	Yes	Yes
Servier	TIBSOVO	ivosidenib	TABLET;ORAL	211192-001	Jul 20, 2018		RX	Yes	Yes

International Patents for Servier Drugs

Country	Patent Number	Estimated Expiration
South Korea	20160124914
Spain	2740424
Argentina	089768
South Korea	20140127255
World Intellectual Property Organization (WIPO)	2015138839
Taiwan	201843136
Japan	6313714

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Servier